Ken Davis

President and CEO, Mount Sinai Health System (Festival Underwriter); Trustee, The Aspen Institute

Ken Davis is CEO and president of Mount Sinai Health System. He is a leader in the move away from fee-for-service medicine to population health, keeping more patients healthy and out of the hospital. As a neurobiologist, his Alzheimer’s disease research led the FDA to approve three of the first four treatment drugs on the market. An elected member of the Institute of Medicine and author of more than 575 scientific articles, Davis is a highly cited researcher in the field of brain diseases. His numerous honors include the George H. W. Bush Lifetime of Leadership Award from Yale University. He is a trustee of the Aspen Institute.

Videos/Audio of Ken Davis

The world of health care, and how to deliver it, is a constant topic for headlines. Beyond congressional wrangling over... See more
Many health systems are retooling to provide “patient-centered care,” defined by the Institute of Medicine as a... See more
Medicine is being disrupted from every angle, as the financing and organization of clinical care are overhauled and... See more
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs... See more
A lot of the discussion about the Affordable Care Act in the lead-up to the election is focused backward. How well has... See more
Over the past decade, coalitions in about a dozen countries have embraced initiatives based on a desired outcome in... See more

Pages